Public-Private Mix

PUBLIC-PRIVATE PARTNERSHIPS FOR PUBLIC HEALTH

Public-private partnerships (PPPs) are becoming a popular mode of tackling large, complicated, and expensive public health problems. However, little is known about the conditions when partnerships succeed, about the strategies for structuring partnerships, or about the ethical underpinnings of partnerships. This book from the Harvard Center for Population and Development Studies presents the results of a workshop examining questions about public-private partnerships in international public health, focusing on the organisational and ethical challenges of partnerships, and ways to address them. The essays in this volume offer some new perspectives on partnerships and provide empirical evidence of both benefits and challenges of PPPs.

Public-Private Partnerships for Public Health
Harvard Series on Population and International Health

Global health problems require global solutions, and public-private partnerships are increasingly called upon to provide these solutions. Such partnerships involve private corporations in collaboration with governments, international agencies, and non-governmental organizations. They can be very productive, but they also bring their own problems. This volume examines the organizational and ethical challenges of partnerships and suggests ways to address them. How do organisations with different values, interests, and worldviews come together to resolve critical public health issues? How are shared objectives and shared values created within a partnership? How are relationships of trust fostered and sustained in the face of the inevitable conflicts, uncertainties, and risks of partnership? This book focuses on public-private partnerships that seek to expand the use of specific products to improve health conditions in poor countries. The volume includes case studies of partnerships involving specific diseases such as trachoma and river blindness, international organizations such as the World Health Organization, multinational pharmaceutical companies, and products such as medicines and vaccines. Individual chapters draw lessons from successful partnerships as well as troubled ones in order to help guide efforts to reduce global health disparities.

Public-private partnerships increasing access to essential drugs
Matlin SA, de Francisco A and Sundaram L: Global Forum for Health Research and Health Partnerships Review, 2008

Data from every part of the world shows that those who are least well off have shorter life expectancies and heavier burdens of disease than those who are relatively wealthy. Subsequently, public-private partnerships (PPPs) have gained growing popularity as mechanisms for increasing access to essential drugs. This series of chapters examines the characteristics of PPPs that aim to improve the health of the world’s poorest people. The authors contribute to the debate about the future role of PPPs and provide pointers to key areas for urgent attention to sustain and increase the momentum to reach the goals towards which PPPs are striving. Issues highlighted include the roles of different actors in partnerships involving public sector and philanthropic donors, the private sector, nongovernmental organisations, communities and researchers in developed and developing countries. The picture that emerges is multifaceted and complex. The PPP approach has evidently focused attention on some neglected areas and has galvanised action that is bringing new resources and innovative solutions to address some health problems. But many challenges remain if their promise is to be fulfilled, including greater and more sustainable financing over the longer term and better mechanisms for coordination. The authors highlight that the ethical imperative of reducing health inequities - closing the gap between the health of the poorest and those who are better off - demands the utmost collective effort.

Public-private partnerships policy and practice: A reference guide
Yong HK (ed): Commonwealth Secretariat, September 2010

This reference guide on public-private partnerships (PPP) theory and practice is intended for senior policy-makers and other public sector officials in developing countries. The guide, available on order from the Commonwealth Secretariat, focuses on the key lessons learned and emerging best practice from successful and failed PPP transactions over the past thirty years. The guide provides a background to PPPs: concepts and key trends; the infrastructure PPP project development process; constraints to infrastructure PPPs and measures to alleviate them; donor initiatives to support infrastructure PPPs; recent PPP experience in Commonwealth developing countries and lessons learned and emerging best practices on PPPs.

Public-private partnerships reducing malaria in Africa: Partnership for a better life
International Information Programs, 3 May 2006

In sub-Saharan Africa, more than 2 million people die each year as a result of malaria; most victims are pregnant women and children under the age of 5. In Mali, malaria is the Number 1 killer of young children.Insecticide-treated mosquito nets are one of the most effective methods for preventing malaria. Studies conducted since the early 1990s show that their use has decreased severe malaria by 45 percent, premature births by 42 percent and all causes of child mortality by 20 percent. The NetMark Alliance represents a time-limited investment by the U.S. Agency for International Development (USAID) to reduce the burden of malaria in sub-Saharan Africa by increasing the commercial supply of insecticide-treated nets.

Public-private partnerships to build human capacity in low income countries: findings from the Pfizer program
Vian T, Richards SC, McCoy K, Connelly P, Feeley F: Human Resources for Health 5:8

The ability of health organizations in developing countries to expand access to quality services depends in large part on organizational and human capacity. Capacity building includes professional development of staff, as well as efforts to create working environments conducive to high levels of performance. The current study evaluated an approach to public-private partnership where corporate volunteers give technical assistance to improve organizational and staff performance. From 2003 to 2005, the Pfizer Global Health Fellows program sent 72 employees to work with organizations in 19 countries. This evaluation was designed to assess program impact.

Public-private partnerships to build human capacity in low income countries: findings from the Pfizer program
Vian T, Richards SC, McCoy K, Connelly P, Feeley F: Human Resources for Health 5:8, 2 March 2007

The ability of health organizations in developing countries to expand access to quality services depends in large part on organisational and human capacity. Capacity building includes professional development of staff, as well as efforts to create working environments conducive to high levels of performance. The current study evaluated an approach to public-private partnership where corporate volunteers give technical assistance to improve organizational and staff performance. From 2003 to 2005, the Pfizer Global Health Fellows program sent 72 employees to work with organizations in 19 countries. This evaluation was designed to assess program impact.

Public-Private Partnerships, Financial Extraction and the Growing Wealth Gap
Hildyard N: Manchester Business School, Centre for Research on Socio-Cultural Change (CRESC), July 2014

This presentation looks at Public-Private Partnerships (PPPs) in infrastructure through the lens of inequality, as wealth becomes concentrated in fewer and fewer hands and as the gap between rich and poor widens globally, regionally and within countries. PPPs are now used in more than 134 developing countries, are on the rise in the aftermath of the 2008 global financial crisis, and have moved from physical infrastructure into the provision of “social infrastructure,” such as schools, hospitals and health services. For the private sector, a PPP project needs to provide a stable, guaranteed income stream. Projects are devised to create multiple avenues for a flow of money that is transformed into private profit through loans, derivatives, shares, securitised income streams, and contract sales that anyone can buy and sell. The author argues that a PPP project enables millions of dollars worth of ancillary trading, mainly for the purpose of hedging risks. The choice of what infrastructure to build is thus argued to be heavily influenced by what serves the long-term profit-making interests of the private sector – and the state or public sector becomes more and more aligned with the interests of infrastructure investors and private companies. PPPs are thus reported to be not about building and providing public services but about constructing the subsidies, fiscal incentives, capital markets, regulatory regimes and other support systems necessary to transform “infrastructure” into an asset class that yields above average returns of 13-25%.

Public-private partnerships. Partnerships for public health
Multi Stakeholder Processes

Public-private partnerships are becoming a popular mode of tackling large, complicated, and expensive public health problems. The idea of partnerships for public health has emerged in national and international policy discussions, in both rich and poor countries. Yet we are still learning about how best to manage these new partnerships, as is discussed in this book.

Public-Private Partnerships: Beneficial or undermining?
Menichini M: Geneva Health Forum, 30 August 2006

What conditions lead to efficient PPP's? Should we reject PPP's all together? Should governments do more in terms of Research and Development (R&D)? There are no straightforward answers but the speakers at this symposium offered convincing and interesting solutions.

Pages